In vivo efficacy of meropenem with a novel non--lactam–-lactamase inhibitor, nacubactam, against gram-negative organisms exhibiting various resistance mechanisms in a murine complicated urinary tract infection model

Marguerite L. Monogue, Sara Giovagnoli, Caterina Bissantz, Claudia Zampaloni, David P. Nicolau

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'In vivo efficacy of meropenem with a novel non--lactam–-lactamase inhibitor, nacubactam, against gram-negative organisms exhibiting various resistance mechanisms in a murine complicated urinary tract infection model'. Together they form a unique fingerprint.

Medicine & Life Sciences